Study: No Consensus on ICD-10 Codes for Adverse Drug Events

Medical literature authors vary widely in the ICD-10 codes they use to identify adverse drug events in administrative data, according to a study published in the Journal of the American Medical Informatics Association.

Advertisement

The researchers applied a systematic search strategy to five electronic reference databases, which included medical journals, conference proceedings, electronic gray literature and study bibliographies. Of the 41 titles included in the study, the researchers found a total of 827 ICD-10 codes that had been used to identify adverse drug events, with a large degree of variability between studies in the numbers and types of codes used.

These findings provide a basis for establishing comprehensive and agreed-upon code sets for identifying adverse drug events in administrative health data, according to the researchers.

More Articles on ICD-10:
The Financial Risks of Transitioning to ICD-10: Key Considerations for Hospitals and Health Systems
CMS Releases Draft ICD-10 Definitions Manual, Code Editor
CMS Might Change Course on ICD-10 End-to-End Testing 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.